Presentation Meta-analysis of Culprit-only vs Multivessel PCI in Patients With STEMI December 15, 2017
Presentation Impact of Access Site on Outcomes in STEMI Patients Undergoing PCI After Thrombolysis November 27, 2017
Presentation AHA 2017 Subgroup Analysis from the RE-DUAL PCI Trial Presenter: Jonas Oldgren November 14, 2017
Presentation Cardiovascular Interventions 2017 PCI for STEMI Patients With Multivessel Disease: Fix The Culprit or All Lesions? Presenter: Cindy L. Grines November 10, 2017
Presentation Cardiovascular Interventions 2017 Precision PCI Takes The Mystery Out Of Angioplasty Presenter: Richard Shlofmitz November 09, 2017
Presentation Cardiovascular Interventions 2017 Tips and Tricks for PCI Success Presenter: Curtiss T. Stinis November 08, 2017
Presentation Cardiovascular Interventions 2017 The Hybrid Approach to CTO PCI Presenter: Bill Lombardi November 08, 2017
Presentation TCT 2017 FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease Presenter: Gregg W. Stone, William F. Fearon November 02, 2017
Presentation TCT 2017 ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease Presenter: Gregg W. Stone, Rasha Al-Lamee November 02, 2017
Presentation TCT 2017 Case #2 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Complex Multi-stent PCI or Any PCI for ACS Presenter: Renato D. Lopes, David J. Moliterno, Sheila Sahni November 01, 2017
Presentation TCT 2017 Case #2 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Complex Multi-stent PCI or Any PCI for ACS Presenter: Renato D. Lopes, David J. Moliterno, Sheila Sahni November 01, 2017
Presentation TCT 2017 Case #1 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD Presenter: Renato D. Lopes, David J. Moliterno, Amit N Vora November 01, 2017
Presentation TCT 2017 Case #1 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD Presenter: Renato D. Lopes, David J. Moliterno, Amit N Vora November 01, 2017
Presentation TCT 2017 Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS? Presenter: Samir R. Kapadia, Ioanna Kosmidou November 01, 2017
Presentation TCT 2017 Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure? Presenter: Samir R. Kapadia, David J. Moliterno November 01, 2017
Presentation TCT 2017 Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping Presenter: Samir R. Kapadia, Sameer Gafoor November 01, 2017
Presentation TCT 2017 Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset Presenter: Samir R. Kapadia, Brian K. Whisenant November 01, 2017
Presentation TCT 2017 Rationale and Potential Role for LAA Closure in the PCI and ACS Patient Presenter: Samir R. Kapadia, Ashish Pershad November 01, 2017